Cellulose membranes suppress complement activation in patients after hemodialysis

Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of kidney diseases 2001-08, Vol.38 (2), p.384-389
Hauptverfasser: Ohi, Hiroyuki, Tamano, Mariko, Sudo, Sukemasa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 389
container_issue 2
container_start_page 384
container_title American journal of kidney diseases
container_volume 38
creator Ohi, Hiroyuki
Tamano, Mariko
Sudo, Sukemasa
description Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity could be altered by dialysis. We measured complement activation in vitro in serum from patients randomized to dialysis treatments using different types of membranes. The classical pathway was activated with aggregated immunoglobulin G (IgG), and the alternative pathway was activated with inulin. Both the classical and alternative pathways were suppressed after dialysis using cellulose membranes (aggregate IgG, P [lt ] 0.01; inulin, P [lt ] 0.001). When polyacrylonitrile (PAN) or polyethylene glycol grafted cellulose membranes were used for dialysis, only minor suppression of complement pathways was measured. Levels of the control factor SP-40,40 increased at later times for dialysis using cellulose membranes (P [lt ] 0.05). Factor H levels were also greater after dialysis using cellulose membranes compared with PAN membranes (P [lt ] 0.05). In summary, cellulose membranes suppress complement activation in serum. One suppressing factor may be the complement control factor SP-40,40. [copy ] 2001 by the National Kidney Foundation, Inc.
doi_str_mv 10.1053/ajkd.2001.26106
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71050334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272638601544534</els_id><sourcerecordid>71050334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-7aea18a85a5f314266da83ffcf8d0ae2b77cfdc1c2a7d129e6ff8c92b62b1bcc3</originalsourceid><addsrcrecordid>eNp1kE1r3DAQhkVpaLZpz70FH0pv3uhjLcnHsKRpIFAKyVmMpRFVaq8djR3Iv4-2u5BccppheOZl5mHsm-BrwRt1AQ__wlpyLtZSC64_sJVopKq1VfYjW3FpZK2V1afsM9ED57xVWn9ip0JsTCu0XrE_W-z7pR8JqwGHLsMOqaJlmjISVX4cph4H3M0V-Dk9wZzGXZV21VS6MqUK4oy5-ovDGBL0z5ToCzuJ0BN-PdYzdv_z6m77q779fX2zvbytvTJyrg0gCAu2gSYqsZFaB7AqRh9t4ICyM8bH4IWXYIKQLeoYrW9lp2UnOu_VGftxyJ3y-LggzW5I5Ms35YVxIWeKIK7UpoAXB9DnkShjdFNOA-RnJ7jbW3R7i25v0f23WDbOj9FLN2B45Y_aCvD9CAB56GPR5hO9yTWNbW3B2gOGxcNTwuzIF20eQ8roZxfG9O4NL5SqkKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71050334</pqid></control><display><type>article</type><title>Cellulose membranes suppress complement activation in patients after hemodialysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ohi, Hiroyuki ; Tamano, Mariko ; Sudo, Sukemasa</creator><creatorcontrib>Ohi, Hiroyuki ; Tamano, Mariko ; Sudo, Sukemasa</creatorcontrib><description>Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity could be altered by dialysis. We measured complement activation in vitro in serum from patients randomized to dialysis treatments using different types of membranes. The classical pathway was activated with aggregated immunoglobulin G (IgG), and the alternative pathway was activated with inulin. Both the classical and alternative pathways were suppressed after dialysis using cellulose membranes (aggregate IgG, P [lt ] 0.01; inulin, P [lt ] 0.001). When polyacrylonitrile (PAN) or polyethylene glycol grafted cellulose membranes were used for dialysis, only minor suppression of complement pathways was measured. Levels of the control factor SP-40,40 increased at later times for dialysis using cellulose membranes (P [lt ] 0.05). Factor H levels were also greater after dialysis using cellulose membranes compared with PAN membranes (P [lt ] 0.05). In summary, cellulose membranes suppress complement activation in serum. One suppressing factor may be the complement control factor SP-40,40. [copy ] 2001 by the National Kidney Foundation, Inc.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/ajkd.2001.26106</identifier><identifier>PMID: 11479166</identifier><language>eng</language><publisher>Orlando, FL: Elsevier Inc</publisher><subject>Acrylic Resins - pharmacology ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cellulose - pharmacology ; Clusterin ; Complement Activation - drug effects ; Complement C3 - metabolism ; Complement Factor H - analysis ; Complement Inactivator Proteins - analysis ; Emergency and intensive care: renal failure. Dialysis management ; Glycoproteins - analysis ; Humans ; Immunoglobulin G - pharmacology ; Intensive care medicine ; Inulin - pharmacology ; Medical sciences ; Membranes, Artificial ; Middle Aged ; Molecular Chaperones - analysis ; Renal Dialysis ; Reproducibility of Results</subject><ispartof>American journal of kidney diseases, 2001-08, Vol.38 (2), p.384-389</ispartof><rights>2001 The National Kidney Foundation, Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-7aea18a85a5f314266da83ffcf8d0ae2b77cfdc1c2a7d129e6ff8c92b62b1bcc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0272638601544534$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1075898$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11479166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohi, Hiroyuki</creatorcontrib><creatorcontrib>Tamano, Mariko</creatorcontrib><creatorcontrib>Sudo, Sukemasa</creatorcontrib><title>Cellulose membranes suppress complement activation in patients after hemodialysis</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity could be altered by dialysis. We measured complement activation in vitro in serum from patients randomized to dialysis treatments using different types of membranes. The classical pathway was activated with aggregated immunoglobulin G (IgG), and the alternative pathway was activated with inulin. Both the classical and alternative pathways were suppressed after dialysis using cellulose membranes (aggregate IgG, P [lt ] 0.01; inulin, P [lt ] 0.001). When polyacrylonitrile (PAN) or polyethylene glycol grafted cellulose membranes were used for dialysis, only minor suppression of complement pathways was measured. Levels of the control factor SP-40,40 increased at later times for dialysis using cellulose membranes (P [lt ] 0.05). Factor H levels were also greater after dialysis using cellulose membranes compared with PAN membranes (P [lt ] 0.05). In summary, cellulose membranes suppress complement activation in serum. One suppressing factor may be the complement control factor SP-40,40. [copy ] 2001 by the National Kidney Foundation, Inc.</description><subject>Acrylic Resins - pharmacology</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cellulose - pharmacology</subject><subject>Clusterin</subject><subject>Complement Activation - drug effects</subject><subject>Complement C3 - metabolism</subject><subject>Complement Factor H - analysis</subject><subject>Complement Inactivator Proteins - analysis</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Glycoproteins - analysis</subject><subject>Humans</subject><subject>Immunoglobulin G - pharmacology</subject><subject>Intensive care medicine</subject><subject>Inulin - pharmacology</subject><subject>Medical sciences</subject><subject>Membranes, Artificial</subject><subject>Middle Aged</subject><subject>Molecular Chaperones - analysis</subject><subject>Renal Dialysis</subject><subject>Reproducibility of Results</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1r3DAQhkVpaLZpz70FH0pv3uhjLcnHsKRpIFAKyVmMpRFVaq8djR3Iv4-2u5BccppheOZl5mHsm-BrwRt1AQ__wlpyLtZSC64_sJVopKq1VfYjW3FpZK2V1afsM9ED57xVWn9ip0JsTCu0XrE_W-z7pR8JqwGHLsMOqaJlmjISVX4cph4H3M0V-Dk9wZzGXZV21VS6MqUK4oy5-ovDGBL0z5ToCzuJ0BN-PdYzdv_z6m77q779fX2zvbytvTJyrg0gCAu2gSYqsZFaB7AqRh9t4ICyM8bH4IWXYIKQLeoYrW9lp2UnOu_VGftxyJ3y-LggzW5I5Ms35YVxIWeKIK7UpoAXB9DnkShjdFNOA-RnJ7jbW3R7i25v0f23WDbOj9FLN2B45Y_aCvD9CAB56GPR5hO9yTWNbW3B2gOGxcNTwuzIF20eQ8roZxfG9O4NL5SqkKw</recordid><startdate>20010801</startdate><enddate>20010801</enddate><creator>Ohi, Hiroyuki</creator><creator>Tamano, Mariko</creator><creator>Sudo, Sukemasa</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010801</creationdate><title>Cellulose membranes suppress complement activation in patients after hemodialysis</title><author>Ohi, Hiroyuki ; Tamano, Mariko ; Sudo, Sukemasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-7aea18a85a5f314266da83ffcf8d0ae2b77cfdc1c2a7d129e6ff8c92b62b1bcc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acrylic Resins - pharmacology</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cellulose - pharmacology</topic><topic>Clusterin</topic><topic>Complement Activation - drug effects</topic><topic>Complement C3 - metabolism</topic><topic>Complement Factor H - analysis</topic><topic>Complement Inactivator Proteins - analysis</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Glycoproteins - analysis</topic><topic>Humans</topic><topic>Immunoglobulin G - pharmacology</topic><topic>Intensive care medicine</topic><topic>Inulin - pharmacology</topic><topic>Medical sciences</topic><topic>Membranes, Artificial</topic><topic>Middle Aged</topic><topic>Molecular Chaperones - analysis</topic><topic>Renal Dialysis</topic><topic>Reproducibility of Results</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohi, Hiroyuki</creatorcontrib><creatorcontrib>Tamano, Mariko</creatorcontrib><creatorcontrib>Sudo, Sukemasa</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohi, Hiroyuki</au><au>Tamano, Mariko</au><au>Sudo, Sukemasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cellulose membranes suppress complement activation in patients after hemodialysis</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2001-08-01</date><risdate>2001</risdate><volume>38</volume><issue>2</issue><spage>384</spage><epage>389</epage><pages>384-389</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity could be altered by dialysis. We measured complement activation in vitro in serum from patients randomized to dialysis treatments using different types of membranes. The classical pathway was activated with aggregated immunoglobulin G (IgG), and the alternative pathway was activated with inulin. Both the classical and alternative pathways were suppressed after dialysis using cellulose membranes (aggregate IgG, P [lt ] 0.01; inulin, P [lt ] 0.001). When polyacrylonitrile (PAN) or polyethylene glycol grafted cellulose membranes were used for dialysis, only minor suppression of complement pathways was measured. Levels of the control factor SP-40,40 increased at later times for dialysis using cellulose membranes (P [lt ] 0.05). Factor H levels were also greater after dialysis using cellulose membranes compared with PAN membranes (P [lt ] 0.05). In summary, cellulose membranes suppress complement activation in serum. One suppressing factor may be the complement control factor SP-40,40. [copy ] 2001 by the National Kidney Foundation, Inc.</abstract><cop>Orlando, FL</cop><pub>Elsevier Inc</pub><pmid>11479166</pmid><doi>10.1053/ajkd.2001.26106</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0272-6386
ispartof American journal of kidney diseases, 2001-08, Vol.38 (2), p.384-389
issn 0272-6386
1523-6838
language eng
recordid cdi_proquest_miscellaneous_71050334
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acrylic Resins - pharmacology
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Cellulose - pharmacology
Clusterin
Complement Activation - drug effects
Complement C3 - metabolism
Complement Factor H - analysis
Complement Inactivator Proteins - analysis
Emergency and intensive care: renal failure. Dialysis management
Glycoproteins - analysis
Humans
Immunoglobulin G - pharmacology
Intensive care medicine
Inulin - pharmacology
Medical sciences
Membranes, Artificial
Middle Aged
Molecular Chaperones - analysis
Renal Dialysis
Reproducibility of Results
title Cellulose membranes suppress complement activation in patients after hemodialysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A57%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cellulose%20membranes%20suppress%20complement%20activation%20in%20patients%20after%20hemodialysis&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Ohi,%20Hiroyuki&rft.date=2001-08-01&rft.volume=38&rft.issue=2&rft.spage=384&rft.epage=389&rft.pages=384-389&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/ajkd.2001.26106&rft_dat=%3Cproquest_cross%3E71050334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71050334&rft_id=info:pmid/11479166&rft_els_id=S0272638601544534&rfr_iscdi=true